Medpace Holdings Inc (MEDP) — Titan Protect Analysis

MEDP

Medpace Holdings Inc

Healthcare · ·

$454.25

Data: 2026-06-03

✓ ETHICAL PASS

NARROW MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$12.6B

Total market value of the company

Trailing P/E

27.84

Premium valuation

Forward P/E

23.81

Based on estimated future earnings — lower means cheaper

Rev Growth

+26.5%

Year-over-year revenue change

Profit Margin

17.2%

How much profit the company keeps from each dollar of revenue

ROE

77.3%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$456.00

+0% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 12 analysts covering this stock

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management,

https://www.medpace.com

Country: United States Employees: 6,300 Industry: Diagnostics & Research

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

0.367

Positive but modest risk-adjusted returns

Kelly Fraction

0.0437

Modest edge detected — smaller position warranted

Calmar Ratio

0.155

Drawdown risk outweighs the returns — higher risk profile

Annual Return

6.1%

Historical annualised return based on price data

Max Drawdown

-39.4%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.19

Moves slightly more than the broader market

52W High

$628.92

28% below the year high

52W Low

$293.20

55% above the year low

Avg Volume

376,761

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.9

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$15.87

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

24.42

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

71.9%

Revenue left after cost of goods — higher means pricing power

Operating Margin

20.0%

Profit from core operations before interest and tax

Free Cash Flow

$491M

Positive — the business generates more cash than it spends

Revenue (TTM)

$2.7B

Total revenue over the last 12 months

Net Income

$460M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$495.00

Target Median

$456.00

Target Low

$329.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
2026-05-15	David Taylor	Republican	Purchase	1K–15K
15 May2026	David Taylor	Republican	buy	1K–15K
15 May2026	David Taylor	Republican	buy	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go